HHS-OIG – Page 8 – Policy & Medicine

HHS OIG Issues Advisory Opinion on Provider-Paid Travel for Rare Disease Patients

Patient Services, Inc. Settlement and Corporate Integrity Agreement

ResMed Corp. $37.5 Million Settlement and Corporate Integrity Agreement

OIG Report Questions the Use of Medicare Advantage Chart Reviews

HHS OIG Publishes Semiannual Report to Congress Detailing Almost $6 Billion in Fraud Recoveries

Medicare Part D Still Paying for Medicare Part A Hospice Drugs

HHS Recommendations to Reduce Fraud, Waste and Abuse Take Aim at CMS and Increased Oversight of Compounded Drugs

HHS OIG Posts Findings Following Opioid Prescribing Review

HHS OIG Report: Using Health IT for Care Coordination

HHS Inspector General Stepping Down Next Month